Most aesthetic clinics have a well-developed answer for the lower face, the neck and the body. Far fewer have a credible answer for the eyes. Patients ask about crepey eyelids, fine lines and tired-looking eyes constantly, and a growing number also arrive with gritty, irritated, watering eyes that no amount of drops seems to settle.
Envision by InMode was built for precisely this gap. It is a multi-modality platform engineered for the periorbital region, designed to treat the medical causes of dry eye alongside the aesthetic concerns of the surrounding skin. For clinic owners weighing their next investment, this guide explains the opportunity, the technology and the questions worth asking before committing.
The Scale of the Dry Eye Problem in the UK
The commercial logic for Envision starts with how widespread dry eye disease actually is. A cross-sectional study from Aston University, which applied the current international diagnostic criteria to UK volunteers, concluded that approximately one-third of the adult UK population have dry eye disease, in line with prevalence reported in multiple countries globally. Prevalence is higher in women than in men and rises with age, with the majority of individuals affected aged over fifty.
That demographic will be familiar to any clinic owner. It overlaps almost exactly with the patient base already walking through the door for skin tightening, menopause-related concerns and facial rejuvenation. Many of these patients have been managing symptoms for years with over-the-counter drops, warm compresses and lid wipes, with limited success. They are motivated, underserved and often already in a treatment relationship with a clinic that cannot currently help them.
Why Drops Alone Often Fall Short
The majority of dry eye cases are evaporative rather than caused by a lack of tears. The root cause is usually Meibomian Gland Dysfunction, where the small glands along the eyelid margin that produce the oily layer of the tear film become blocked, thickened or inflamed. Without that oil layer, tears evaporate too quickly and the eye surface becomes irritated. Ocular rosacea and chronic inflammation of the lid margin frequently sit alongside it.
Lubricating drops address the symptom by adding moisture to the surface. They do nothing to restore gland function or interrupt the inflammatory cycle driving the condition. This is why so many patients report that drops provide only short-lived relief. Treatments that act on the glands and the inflammation itself are what change the picture, and that is where energy-based devices have a role.
How Envision Treats the Eye Area
Envision combines three complementary technologies on one intelligent workstation, each adapted with small applicators and tightly controlled depth settings for the delicate tissue around the eyes.
Forma-I bipolar radiofrequency
Forma-I delivers gentle, uniform radiofrequency heating to the eyelids and periorbital area. The controlled warmth is designed to stimulate the meibomian glands, helping to restore healthy oil production and improve local circulation, while easing the inflammation that drives discomfort. Built-in temperature sensors monitor the tissue throughout so the energy stays within a safe, comfortable range in this sensitive zone.
Lumecca-I intense pulsed light
Lumecca-I uses short, high-intensity pulses of broadband light to interrupt the inflammatory cycle that underpins ocular surface disease, and to reduce the vascular and pigmented changes often seen with ocular rosacea. Its small spot size and advanced Xenon flash lamp allow precise, targeted treatment, and it is optimised for use across light and dark skin tones.
Morpheus8 fractional RF microneedling
The third handpiece addresses the skin itself. Morpheus8 delivers fractional radiofrequency through fine microneedles to remodel collagen, tighten crepey periorbital skin and soften fine lines. If your clinic already offers Morpheus8 elsewhere on the face, the Envision configuration extends that familiar technology into an area that conventional tips cannot safely reach. For a fuller explanation of the mechanism, see our guide to what Morpheus8 is and how RF microneedling tightens skin.
Together, the three technologies allow a clinic to treat function and appearance within a single protocol, which is unusual in a sector where medical and aesthetic concerns are normally handled in separate rooms by separate practitioners.
Where Envision Sits Commercially
Envision creates a treatment category rather than adding another option to an existing one. Ocular wellness combines elements of optometry, ophthalmology and aesthetic medicine, and it is this convergence that gives the platform its commercial character.
The broader trend of aesthetic clinics moving into genuinely medical territory is one we covered in our review of the 2026 aesthetic treatment trends UK clinics should know about, and Envision is one of its clearest examples.
Several features of the model are worth drawing out for a clinic owner.
Recurring, protocol-based revenue
Dry eye is a chronic condition, which means treatment is typically delivered as a short course followed by periodic maintenance. Patients who experience relief tend to return, and the periorbital aesthetic treatments can be layered into the same visits. This is the kind of predictable, repeat revenue that supports a sound return on a capital investment.
Referral relationships with eye care professionals
Optometrists and ophthalmologists see dry eye patients every day and frequently have limited in-practice options to offer beyond drops and lid hygiene. An aesthetic clinic equipped with Envision becomes a natural referral destination, and the relationship often works in both directions.
A fit for eye care practices as well as aesthetic clinics
Envision is not only an aesthetic clinic purchase. Optometry and ophthalmology practices are increasingly using it to bring dry eye management in-house and, in some cases, to add a periorbital aesthetic offering to an existing patient base that trusts them. InMode UK works with practitioners across both settings, and the specialist conversation differs accordingly.
Differentiation in a crowded market
Few platforms on the UK market are purpose-built for the eye area. Offering a treatment most local competitors cannot is a straightforward way to stand out, and the medical nature of the service supports a credible, clinically led positioning.
Questions to Ask Before You Commit
A good device investment starts with an honest look at the practice rather than the brochure.
Consider first whether your current patient base already includes the people most likely to benefit. If a significant proportion of your patients are women over forty presenting for facial treatments, the dry eye and periorbital demand is almost certainly already present, whether or not anyone has asked about it yet.
Consider next who will deliver the treatments. Envision is designed with preset parameters and an intuitive interface that shortens the learning curve, and InMode provides clinical training and ongoing support, but the practitioner needs to be comfortable assessing and treating the eye area and recognising when a patient should be referred onward.
Consider finally how the platform complements what you already run. If Morpheus8 is already part of your menu, Envision deepens it. If you are building a combination treatment model, the way its three technologies layer within a single protocol fits naturally with the approach described in our article on the rise of combination treatments in modern aesthetic practice.
The Evidence Behind our Technologies
The radiofrequency and IPL technologies on the Envision platform are supported by published clinical research, and a Morpheus8 protocol for recurrent eyelid oedema following hyaluronic acid filler has been published in the Aesthetic Surgery Journal Open Forum.
InMode maintains a library of peer-reviewed studies that practitioners can draw on during consultations, available on the clinical studies page.
See Whether Envision Could Open Ocular Wellness for Your Clinic
Envision gives a clinic the ability to treat one of the most common and most under-addressed conditions in the UK, while rejuvenating the eye area at the same time, from a single platform built specifically for that purpose.
If you would like to understand how it might fit your patient demographics and your existing technology, the InMode UK device specialists would be glad to talk it through. They can assess your clinic’s position, arrange a demonstration and help you decide whether this is the right moment to expand into ocular wellness. Get in touch with the team to start the conversation.